More pharmacies in England to prescribe medication from autumn
Expansion of Pharmacy Prescribing in England
More pharmacies in England to prescribe – Starting in autumn, a significant development in England’s healthcare system will allow an increased number of pharmacies to offer prescription services. This initiative aims to streamline patient care and reduce the burden on general practitioner (GP) clinics and hospital departments. By empowering pharmacists with more prescribing authority, the government hopes to improve access to treatment and support a more efficient healthcare delivery model.
Pharmacy First Scheme Overview
The Pharmacy First scheme, introduced in 2024, already enables pharmacists to manage a variety of health conditions. Patients can receive advice, over-the-counter remedies, and prescription medications for ailments such as sore throats, earaches, sinus infections, shingles, impetigo, infected bites, and urinary tract infections. Additionally, the scheme includes services for eye, ear, oral, and dental care, as well as treatments for digestive issues. This approach has been designed to reduce waiting times and provide immediate care, leveraging the skills of pharmacists to complement traditional GP services.
New Ailments to be Added
As part of a broader strategy, the government has announced a £340 million investment to expand the scheme. This funding will allow pharmacists to prescribe for five additional common health problems, though the specific conditions have not yet been revealed. The inclusion of these new ailments is expected to further ease the pressure on overburdened GPs and hospitals, particularly during peak seasons. However, the National Pharmacy Association (NPA) has expressed reservations, arguing that the plan does not fully account for the financial strain pharmacies are already facing.
Government’s Investment and Benefits
Health Minister Stephen Kinnock has highlighted the government’s commitment to utilizing pharmacists’ expertise to transform healthcare accessibility. “Independent prescribing will be a key factor in this shift, helping to reduce the administrative load on GPs and ensuring patients receive the right care closer to home,” he explained. The minister emphasized that this move is part of a broader effort to modernize the healthcare system, enabling quicker responses to health concerns and fostering a more patient-centered model of care. According to official data, over 3.3 million consultations under the Pharmacy First scheme were completed between March 2025 and February 2026, demonstrating its growing impact on local healthcare services.
Pharmacies’ Concerns Over Funding
Despite the positive momentum, the NPA has pointed out that the current funding level is insufficient to address critical financial challenges. The association highlighted that the initiative does not adequately cover rising operational costs, including increased business rates and the ongoing pressure of medicine prices. Dr. Olivier Picard, the NPA’s chairman, stated that the scheme “points in the right direction” but falls short of resolving the “crippling” financial strain on pharmacies. He also noted that the expanded program is “nowhere near ambitious enough to transform patient access to care” or fully utilize pharmacists’ skills. “Many pharmacies will struggle to maintain this progress, risking its long-term success,” he added, stressing the need for more substantial financial backing.
Industry Leaders’ Perspectives
Dr. Leyla Hannbeck, CEO of the Independent Pharmacies Association, which represents around 5,000 pharmacies in England and Wales, echoed similar concerns. She acknowledged the changes as “a step in the right direction” but warned that the funding allocated “does not cover the workload to do this.” “Pharmacists are now considering whether they can sustain their operations with the current financial support,” she said during an interview on BBC Radio 4’s Today programme. “Many are questioning their ability to keep their heads above water as they take on more responsibilities.” The association is calling for a more comprehensive funding strategy to ensure the scheme’s success and to prevent pharmacies from being overextended.
Impact on Patient Care and Healthcare Systems
The expansion of the Pharmacy First scheme is seen as a potential game-changer for the healthcare landscape. By allowing pharmacists to handle more conditions, patients can avoid unnecessary visits to GP surgeries, where wait times have often been a source of frustration. This shift not only improves convenience for individuals but also optimizes the use of healthcare professionals, freeing up GPs to focus on more complex cases. However, the NPA warns that without additional investment, the benefits may be limited. “The funding levels mean that many pharmacies will find it challenging to take this development forwards,” Dr. Picard said, emphasizing the need for a long-term strategy to support the initiative.
Broader Implications for the NHS
The NHS has previously identified a £2.5 billion funding gap, which the NPA argues this expansion does little to address. While the £340 million investment is a positive step, industry leaders believe it is insufficient to cover the full scope of challenges. “The current deal fails to tackle the rising costs that pharmacies are encountering,” Dr. Hannbeck noted. She also raised concerns about the sustainability of pharmacists’ work, suggesting that the scheme may become a “loss-making endeavor” if financial support remains inadequate. The NPA is urging policymakers to consider the broader implications of the funding decisions and to ensure that the expansion aligns with the NHS’s long-term goals of improving patient outcomes and reducing healthcare pressures.
Looking Ahead
As the autumn rollout approaches, the focus will be on how effectively the expanded scheme can meet its objectives. While the government has outlined its vision, the success of the initiative will depend on the collaboration between pharmacies, healthcare providers, and policymakers. Industry leaders are hopeful that the scheme will serve as a foundation for further reforms, but they remain cautious. “This is an opportunity to redefine the role of pharmacists in the NHS,” Dr. Picard said. “However, we need to ensure that the financial framework is robust enough to support this transformation.” With the scheme already showing promise, the coming months will be critical in determining whether it can be scaled sustainably and whether it will significantly enhance healthcare access across England.